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PATIENT PROFILE OF ORAL SQUAMOUS CELL CANCER IN GENERAL 
SURGERY OUT PATIENT DEPARTMENT IN CHRISTIAN MEDICAL 
COLLEGE, VELLORE. 
AIM AND OBJECTIVES:  
 
1. To look for the presence of Human Papillomavirus in the oral cavity of patients with oral 
squamous cell carcinoma presenting to the General Surgery Out Patient Department of 
Christian Medical college, Vellore and to compare it with those who do not have 
carcinoma of  the oral cavity.  
 
2. To study the demographic profile of the patients presenting with oral squamous cell 
carcinoma to the General Surgery Out Patient Department. 
 
3. To look for an association between HPV and oral squamous cell cancer by comparing the 
risk factors in those with and without oral cancers. 
 
4. To assess the the presence of Human Papillomavirus to the site of oral squamous cell 
carcinoma  - tongue, buccal mucosa, floor of the mouth, or gingivo – buccal sulcus. 
 
5. To compare the degree of differentiation of the tumour and the presence of Human 
papillomavirus. 
 
6. To evaluate the role of other selected risk factors associated with HPV in causing oral 
squamous cell carcinomas. 
 
  
PRESENT KNOWLEDGE  
 
AND  
 
REVIEW OF LITERATURE 
 
 
 
 
 
 
INTRODUCTION:  
Squamous cell carcinoma of the oral cavity is the sixth most common cancer in the world
1
. In the 
world, the commonest is found to be lung cancers in men and breast cancers in women
2
.Overall, 
head and neck cancer accounts for more than 550,000 cases annually worldwide
3
. In India, the 
incidence is gradually increasing from about 30% to almost 50% in the past decade.  This can be 
due to the increase in the chewing and smoking of tobacco among the people of India
4
. Oral 
cancers have been the cause of morbidity and loss of valuable patient and hospital resources.  
 
 
CAUSATIVE FACTORS: 
 
 
 
The common causes of oral cancers have been studied in great detail and the imperative 
nature of tobacco as a cause in the form of chewing tobacco and the smoking of cigarettes and 
beedis have been proven without any doubt.  The risk factors most frequently associated with 
head and neck cancer include smoking, alcohol consumption, HPV infection (especially for 
oropharyngeal cancers). Many studies done in India and elsewhere have shown an increased 
incidence of oral cancers among those who smoke or chew tobacco. There is an increased risk of 
head and neck cancer, ranging from a 5- to 25-fold, in heavy cigarette smokers compared to non-
smokers. There appears to be a dose-response relationship
5,6
. The main pathophysiology behind 
the causation has been identified as the carcinogens in the tobacco that is chewed or smoked. The 
relative risk (RR) in current tobacco users was 6.5. The RR increased with the duration of 
smoking and gradually declined after smoking cessation with no excess risk at 20 years
7
.  
 
 
 
 
 
 
  The age of starting smoking (less than 18 years of age) and the duration of smoking  
(more than 35 years) were the common risk factors
8
.  Cessation of smoking was associated with 
significant decrease in the relative risk.
9 
Cigar smoking and usage of pipes are associated with an 
increased incidence of head and neck cancer (relative risk 2.0 to 2.6)
10,11 
and smokeless tobacco 
(both chewing tobacco and snuff ) with an increased risk of cancer of the oral cavity and 
pharynx.
12,13,14,15.
 
 
                Alcohol consumption independently increases the risk of cancer in the upper 
aerodigestive tract.But, it is often difficult to separate the effects of smoking and alcohol
16,17. 
The 
relative risk of developing head and neck cancer due to alcohol appears to be dose dependent
17,18.
 
As an example, one study reported a five to six fold increased risk for head and neck cancer with 
alcohol intake greater than 50g/day versus less than 10g/day ( one drink contains approximately 
12g of alcohol.)
18
. Alcohol intake and tobacco smoking appear to have an interactive and 
multiplicative effect on the risk of developing head and neck cancer.
16,17,18. 
 
     Another common cause is due to chronic irritation to the oral mucosa.
19.  
This has  
 
been found true in cases of carcinoma of the lateral border of the tongue where there may be  
 
chronic irritation due to chipped teeth or ill- fitting dentures.
20
 The odds ratio has been found  
 
to be 3.4 as compared with those without any dental problems
19
. The continuous irritation to  
 
the mucosa leads to dysplastic changes which later turn malignant. 
 
 
  There are many factors in play in the causation of oral cancers. This mainly 
involves the dysplastic changes caused in the normal epithelium. There are many premalignant 
conditions that occur which include leukoplakia, erythroplakia and sub mucous fibrosis which in 
turn lead to malignancy. The following picture depicts the changes that occur in the normal 
epithelium leading to cancer formation. 
 
 
 
 
 
HUMAN PAPILLOMA VIRUS AND OROPHARYNGEAL CANCERS: 
 
 
Of recent interest and often studied entity with regard to the causation of oral squamous 
cell cancers is the presence of Human Papillomavirus.
5,6,21,22,23.
 Multiple types of viral infections 
have an established relationship with increased risk of head and neck cancer,  
includingEbstein-Barr virus (EBV) and Human Papillomavirus (HPV). 
 
 
Epidemiological and molecular evidence has established a causal role for HPV, primarily 
those arising in the base of tongue and tonsils. These HPV associated head and neck cancers are 
seen in younger men, who are typically non-users of tobacco and alcohol. HPV is found in the 
oral mucosa and is considered causative in some of the cases, especially in tumours of the 
Waldeyer‟s ring.24 
 
  
Cohort studies from the 1990s suggested that approximately 50 percent of oropharyngeal 
cancers were attributable to HPV, while more recent studies suggest that HPV may account for 
as much as 70 to 80 percentage of these malignancies.
25,26
 
 
 
HUMAN PAPILLOMAVIRUS: 
 
 
 Human Papillomavirus is a double-stranded DNA virus that infects the epithelial 
cells of skin and mucosa. It is made up of approximately 7900 base pairs. DNA sequencing 
techniques have facilitated HPV typing and characterization with each type formally defined as 
distinct having less than 90 percent DNA base pair homology with any other HPV type.
27
 
The moist epithelial surfaces (squamous cells) include all areas covered by skin and /or 
mucosa such as the mouth, throat, tonsils, vagina, penis and anus. 
 
 
 
The above is a picture depicting the Human Papillomavirus.
28 
 
 
 
 Transmission of the virus occurs when these areas come into contact with a virus, 
allowing it to transfer between epithelial cells. While it is now established that sexual contacts 
both conventional and oral are means of transferring the HPV virus, it is still poorly understood   
what other transfer pathways may exist.
29 
 
 
 
CARCINOGENESIS AND HUMAN PAPILLOMAVIRUS 
               There is a need for further knowledge of Human Papillomavirus in the causation 
of oral cancers, as DNA viruses have been found to be causative agents in multiple cancers, 
examples like Ebstein Barr Virus which causes Burkitt‟s lymphoma in people of Africa, 
nasopharyngeal carcinoma, some T-cell and B-cell lymphomas, and 50% of Hodgkin‟s 
lymphomas.With increasing incidence of carcinoma cervix and its proven association with 
Human Papillomavirus
30
, there is now the possibility of prevention of this cancer using vaccines. 
Since the oral squamous epithelium is similar in structure to the cervical epithelium, it has been 
postulated that there may be a common causative organism, namely HPV
30
.  
 
 
  The carcinogenic properties of HPV have been well studied and have been proved 
in the carcinoma cervix
30
. The pathogenesis of this cancer includes HPV oncoproteins and their 
interactions with host cellular oncoproteins. The oncoproteins E6 and E7 are consistently 
expressed in HPV-carrying anogenital cancers.These (E6 and E7) decrease the death of  human 
keratinocytes and mammary epithelial cells, lowering the growth-factor requirement of these 
cells, thereby making them divide without stopping. 
 
 
MOLECULAR CARCINOGENESIS
31
:  
 
                       Carcinogenic progression of lesions infected with HPV16 or HPV18 has been 
associated with integration of the viral genome into the host cell‟s chromosomes. The integration 
occurs in a way that results in the loss of viral E1 and E2 gene expression (disruption of open 
reading frames), whereas the E6 and E7 (the oncoproteins) open reading frames frequently 
remain intact and are actively transcribed. In contrast to the monocistronic mRNA that encodes 
E6 and E7 from low-risk HPV (HPV6 and HPV11), E6 and E7 from high-risk HPVsare 
produced as a bicistronic message. 
 
                       The transforming properties of HPVs are due to the interaction of viral 
oncoproteins with cellular proteins that control cell proliferation and apoptosis. The tumour 
suppressor proteins P53 and PRb are key regulators of cell cycle progression. P53 acts by 
mediating the G1/S checkpoint through transactivation of P21, a cyclin-dependent kinase 
inhibitor. PRbacts by sequestering E2F, a transcription factor that brings about the transcription 
of genes essential for DNA synthesis. E6 protein binds to P53 tumour-suppressor protein through 
its interaction with E6-associated protein ligase, leading to the ubiquitin-dependent degradation 
of P53. This prevents the accumulation of P53 in cells. Thus, HPV is able to overcome its 
growth-arrest and apoptosis-inducing functions. Also, in P53-null mice, HPV E6 still prevents 
the induction of apoptosis
31
. 
                               The proapoptotic protein BAK, from the BCL2 family, is expressed highly in 
the upper layers of epithelium. This is also the site of HPV replication. E6 can inhibit BAK-
induced apoptosis. This explains the chromosomal instability of cells infected with high-risk 
HPV types, leading to carcinogenesis.  The HPV E7 protein can induce growth in various 
established rodent fibroblast line and acts along with E6 to delay, or even prevent cell death of 
primary human keratinocytes. This activates mutational consequences for the cells. These 
mutations are partly explained by the ability of E7 to interact with and to induce destabilisation 
of the „pocket‟ proteins PRb, P107, and P130. These proteins negatively regulate the activity of 
several transcription factors, including members of the E2F family.  This is done by direct 
association. This interaction is a critical factor in uncontrolled growth of cells infected with high-
risk HPVs. In addition, E7 oncoproteins inactivate the inhibitors of cyclin-dependent kinase P21 
and P27
31
. 
  
 
                   This picture depicts the various oncoprotein ligases that disrupt the normal cell 
pathways and lead to dysplasia. 
  
 
 
     Therefore, E7 has the ability to deregulate the cell cycle. Along with this, E7 promotes 
apoptosis(cell death) in cells expressing wild-type P53. Expression of E7 in normal fibroblasts or 
in human keratinocytes induces typical markers of apoptosis.  Thus, the Human Papillomavirus 
affects the cell cycle causing increased proliferation of cells and inhibits apoptosis, thereby 
leading to dysplasia which leads on to malignancy. 
  
    Cytological and histopathologically presence of Koilocytes can indicate the  
presence of Human Papillomavirus. 
 
PICTURE  DEPICTING THE  PROGRESSION  FROM  INFECTION WITH  HPV  TO 
CARCINOGENESIS 
 
 
  
 
 
PICTURE DEPICTING KOILOCYTES IN THE MUCOSAL EPITHELIUM WHICH IS 
CHARACTERISTIC OF HPV INFECTION. 
 
 
 
CLINICOPATHOLOGICAL FEATURES:  
 It is seen that the oral cancers which are positive for Human Papillomavirus differ from 
the regular oral cancers in a few features. Patients with HPV positive oropharyngeal cancer are 
approximately 10 years younger when compared to HPV negative patients.
32,33.  
HPV associated tumors predominantly arise in the base of the tongue or the tonsillar region, 
although a small percentage of tumors at other sites are also HPV positive
1,33,34.
 Multiple 
studies have shown that HPV associated oropharyngeal cancer is more likely to present with  
a relatively early stage (T1/T2) primary tumor, but relatively advanced disease in the neck  
(N2/N3)
33,34. 
HPV testing falls into three main categories
35
:  
 HPV DNA testing – HPV DNA testing was the first approach developed for routine 
clinical testing. Many studies have shown that the addition of HPV DNA testing to 
cervical cytology improved the sensitivity for detection of cervical cancer precursors, 
such as cervical intraepithelial neoplasia (CIN) 2 and 3.  
 HPV RNA testing – HPV RNA testing, where expression of E6 and/or E7 RNA are 
looked for, may be performed with the expectation that active HPV oncogene 
expression would provide better sensitivity and specificity than HPV DNA testing. 
Studies done this far indicate that some of these tests do result in similar sensitivity to 
HPV DNA testing with slightly higher specificity. None of these tests are currently 
FDA-approved, although this is likely to change in the near future.  
                                                          
 
 
 Detection of cellular markers – Cellular marker detection uses a different approach to 
diagnosing HPV-associated disease. The HPV E7 protein disrupts cell cycling leading 
to an increase in cellular p16 protein expression. High-grade CIN lesions contain high 
levels of p16, and pathologists often immunostain cervical biopsies to help distinguish 
between high-grade CIN and immature squamous metaplasia. This is not associated 
with HPV and is not precancerous.  
The method we used was the Real time Polymerase Chain Reaction
36
. The procedure 
follows the general principle of polymerase chain reaction; its key feature is that the amplified 
DNA is detected as the reaction progresses in real time. This is a new approach compared to 
standard PCR, where the product of the reaction is detected at its end. Two common methods for 
detection of products in real-time PCR are: 
 (1) non-specific fluorescent dyes that intercalate with any double-stranded DNA, and 
 (2) sequence-specific DNA probes consisting of oligonucleotides that are labeled with  
a fluorescent reporter which permits detection only after hybridization of the probe with  
its complementary DNA target. 
Frequently, real-time PCR is combined with reverse transcription to quantifymessenger 
RNA and Non-coding RNA in cells or tissues. 
 
 
  
This is a rough algorithm that explains the basic steps in real time PCR amplification. 
 
 
 
 
 The steps involved in a RT-PCR are described below: 
1. The first step is to raise the reaction temperature and melt the dsDNA. 
2. The temperature is then decreased so that specific primers bind to the sequences at each 
end of the target DNA. 
3. The intervening DNA is then synthesized by DNA polymerase reaction in opposite 
direction. As a result of this, we have two double strand copies of the target DNA when 
we started with only one. 
4. To detect the generation of new amplicons in RT-PCR, the PCR reaction requires an 
additional ingredient, a single stranded DNA probe which is designed to hybridise to the 
part of the DNA sequence synthesized between the two primers. 
5. This probe is more defined in a special way where one of its nucleotides is labeled 
covalently with a fluorescent molecule and another nucleotide is labeled with a 
fluorescent quenching molecule.  The quencher rapidly absorbs any light emitted by the 
fluorescent molecule as long as it remains in close proximity. 
6. As the primers bind to the separate strands of DNA, the probe also finds its 
complimentary sites between them.  The enzyme that synthesize new DNA from the end 
of the primers also has a second activity; an exonuclease activity, so when it encounters 
dsDNA in its path, it will disassemble the strand that is in its way and replace all the 
nucleotides. 
7. As the polymerase catch through the probe, the nucleotide bearing the fluorescent marker 
and the one bearing the quencher are separated from one another. In the absence of a 
nearby quencher, the fluorescent molecule can now emit detectable  
light when it is stimulated. 
8. The next step involves the detection and measurement of the light signal.  Each time 
another amplicon is produced, another fluorescent marker is released from its 
neighbouring quencher.  Therefore, just as the number of amplicons doubles in each PCR 
cycle, the amount of emitted fluorescent energy also doubles. 
9. This light generation can be monitored during the PCR reaction in a thermostat lab that is 
equipped with a fluorometer. When we begin with a clinical sample that had only one 
copy of the target DNA, it can take a few more cycles before the amplions are detected 
by a fluorometer in a specialized thermocycle.  So, the amount of specific DNA in the 
clinical sample is determined by the reference to the rounds of PCR in which the amount 
of fluorescence first crosses the threshold of detection. 
10. In cases of viruses with no DNA, the viral RNA from the RNA virus can be quantified 
after it is copied first and is converted to dsDNA 
11. In this case, the RNA is released from the virion.  Then, a complimentary DNA (cDNA) 
strand is synthesised from the viral RNA using purified Reverse Transcriptase.  In some 
protocols, a special RNAse enzyme is then added to nick the RNA and allow it to be 
degraded. The next key step occurs when a DNA polymerse and a primer generates a 
complimentary DNA strand just as in the PCR reaction.  At the end of this reaction, a 
single strand of viral RNA has been converted to a dsDNA that has the same sequence of 
nucleotide base.  The quantitative PCR reaction can proceed as described previously.  
 
 In the light of the above known factors, we decided to look at the presence of Human   
            Papillomavirus in patients with oral cancers and compare them to those without oral          
            cancers. 
 
  
 
 
                      MATERIALS 
                  AND 
                   METHODOLOGY 
 
 
 
 
  
a) Study Design: 
 Prospective, case control study. 
This study was approved by the Institution Review Board (IRB). 
b) Subjects: 
All patients with histologically proven Oral squamous cell carcinomas (confirmed in 
Pathology Department, CMC Vellore) who came to General Surgery I OutPatient department 
were chosen for this study. 
c) Sample size: 
 The samplesize was calculated based on the existing data. The prevalence among the 
cases (exposed) was 40% and the prevalence among the controls (the non-exposed) was 10%. 
When the power of the study was taken as 80% and the significance was calculated to be 5% (p 
value : 0.05) the sample size came to 76 with 38 in each arm. Hence the number of cases and 
controls was decided to be 40 each. This was calculated with the help of a statistician. 
d) Inclusion criteria for cases: 
- Histologically confirmed oral squamous cell carcinoma   
- Any stage of oral squamous cell carcinoma 
- Any gender 
 
e) Exclusion criteria: 
          -  History of previous radiation or chemotherapy 
 - Presence of any premalignant lesions. 
 
f) Case sample: 
 Mucosal scrapings from the oral cavity which was taken using a small brush. 
 
g) Controls:  
 Age and gender matched patients who come to General Surgery OPD for treatment of 
other conditions. 
 
h) Informed consent: 
 Informed consent was taken from all patients enrolled in the study. The consent form  
is attached as Appendix 
 
i) Methodology:  
 
Sample collection and processing of sample: 
 The patients with oral squamous cell cancers were identified as cases and oral mucosal 
scrapings were done. The specimen were collected by the principal investigator using the same 
method  for all patients to prevent bias in the sample collection. The cases were identified, the 
details of the study were explained and  informed consent was obtained. Then the patient was 
asked to open his/her mouth wide. Scrapings were taken from the oral mucosa by gentle sweeps 
along the mucosa in the following areas 
 
1. The right and left buccal mucosa  
2. The right and left upper gingivobuccal sulcus 
3. The right and left lower gingivobuccal sulcus 
4. The right and left lateral borders of the tongue. 
5. The floor of the mouth 
6. The posterior one third of the tongue, which was done last to prevent gag and 
discomfort to the patient. 
7. In patients with oral lesions gentle sweeping of the tumour was also done 
In each of these sites ten strokes of the brush was made to assure the adequacy of 
the sample collected. 
 
  
 
                     The samples were then mixed with the transport media which was a prepacked 
product from Hybribio. This specimen was placed in an ice box and was transported to the 
Department of Virology. In the department these samples were stored at a temperature of 4
o
C till 
they could be processed for the RT PCR. 
 
  
 
  
 
 
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following tables represent the analysis of the data that was collected. 
  
 
 
Figure 1:  
The gender distribution of the cases and controls. The cases were matched with the 
controls based on their gender.  
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Figure 2: 
The following figure shows the geographic representation of the patients who presented 
with oral cancers to the General Surgery OPD 
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Figure 3:  
The education level of the cases and controls were as follows. 
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Further breakdown of education level in the cases and controls was as follows 
Figure 4: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
5
10
15
20
25
30
Nil
Less than 
5th std
6th to 
10th
11th or 
12th
College 
UG
PG
4 (25%) 5 (62.5%)
16 
(57.15%)
7
(53.84%) 7
1 (50%)
12 (75%)
3
(37.5%) 
12 (42.85%)
6 
(46.15%)
6 
(46.15%)
1 (50%)
N
U
M
B
ER
 O
F 
PA
TI
EN
TS
Level of Education
Controls
Cases
 Figure 5: 
 
The following tables show the percentage of people who smoke among the cases and  
 
controls. Smoking is considered one of the common causative factors of Oral Squamous cell  
 
carcinomas. 
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 The smoking habits were further analysed with regard to the number of years of smoking, the 
frequency of smoking and the type of tobacco used. The findings were as follows. 
 
Figure 6:      Frequency of smoking: 
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Figure 7 : Shows the various methods of smoking tobacco
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Figure 8: 
This indicates the number of years the patient had been smoking. 
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Figure 9: 
This graph indicates the number of people who chew tobacco in the cases and the 
 Control group. 
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Figure 10: 
 
The following graph indicates the frequency of chewing tobacco among the cases and  
controls. 
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Figure 11: 
The following table breaks down the different types of tobacco that was chewed among 
the cases and controls. 
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The following table represents the number of years the patients in both the cases and the 
controls group have chewed tobacco. 
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 Figure 13: 
The following graph shows the percentage of people who consumed alcohol in the cases 
and the control group.  
 
 
 
The following tables discuss the type of alcohol consumed in both the cases and the 
control group along with the frequency of consumption and the number of years of consumption 
of alcohol. 
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 Figure 14: 
The following table indicates the number of years of alcohol consumption. 
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Figure 15: 
The different types of alcohol consumed was also compared among the cases and the 
controls to see whether there was a particular type of alcohol which was causative in oral 
cancers. 
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Figure 16:  
The following table indicates the frequency of consuming alcohol. 
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The following tables discuss the other co-morbid conditions that can cause oral 
cancers. The frequency of dental visits and other dental problems are compared with the 
presence or absence of oral cancers. 
 
Figure 17: 
Habit of brushing teeth: 
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Figure 18: 
 
The number of dental visits the patients had before the diagnosis of oral cancer was 
analysed. 
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Figure 19: 
 
Dental problems versus oral cancers. 
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Figure 20: 
 
The following table indicates the number of patients who were using dentures. 
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 The next set of tables discuss the presence of co-morbid conditions like diabetes and 
hypertension which have been found to have a bearing on the patient‟s general condition which 
can predispose him or her to malignancies. Diabetes Mellitus is considered one of the 
immunocompromised states which can lead to the formation of malignancies. 
 
Figure 21: 
Figure comparing the presence or absence of oral squamous cell carcinoma against 
diabetes. 
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Figure 22: 
The number of years of diabetes compared with the presence or the absence of oral 
cancers. 
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Figure 23: 
 
The presence of  Hypertension in those with and without oral cancers 
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 Figure 24:  
 The following graph indicates the presence of oral cancers as compared to the  
duration of hypertension among the cases and controls. 
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The following charts represent the characteristics of the oral carcinoma in the group of patients 
with oral cancer in our study population. This is a way to know the patient profile of the patients 
who come to us with oral cancers. Understanding the kind of patients that we see in our OPD can 
help us cater to their needs better. 
 
Figure 25: 
This following chart divides the oral cancer based on it‟s site in the oral cavity. 
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Figure 26: 
 
This figure divides the oral cancers based on their size. 
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Figure 27: 
Presence of lymph nodes. 
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Figure 28: 
 
The next slide shows the distribution of cases depending on the lymph nodal status. 
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The following table shows the distribution of oral cancers based on their degree of 
differentiation. 
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 Figure 30 : 
The following figure shows the distribution according to TNM staging. 
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ANALYSIS 
 
 
 
 
 
 
 
 
 
                       The following was analysis based on the data collected. The gender distribution of 
the cases was studied. It was seen that 60% of the cases were men and only 40% were women. 
This corresponds to the observed pattern both in India and elsewhere in the world
37
.  There has 
been a male preponderance in the incidence of oral cancers. The trend is changing slightly with 
an increase in smoking among women. But there is still a higher rate of oral cancers among men 
as compared to women. From the above analysis, it was seen that the patient profile of those with 
oral cancers who presented to the General Surgery OPD in our hospital was comparable to the 
data elsewhere. It was seen that there was a slight male preponderance in the number of patients  
with oral carcinoma which was comparable to the data worldwide
2
,
3
.In India, males  are affected 
twice as much as females.
41 
 
 
  The demographic pattern of the patients visiting the General Surgery OPD was 
also studied. It was seen that most of the patients were from South India, mostly from Tamil 
Nadu and Andhra Pradesh. There were also a large percentage of patients who had come from 
West Bengal. This distribution was similar to the patient profile generally seen in the General 
Surgery OPD in our hospital. The majority of patients who attend the outpatient department in 
our Institution are either from Tamil Nadu or West Bengal. Hence this may represent the patient 
profile of the outpatient department rather than the distribution of cases. The highest number of 
                                                          
 
 
 
 
the patients with oral cancers were from Tamil Nadu and the next highest were from West 
Bengal. This may be a reflection of the patient profile of our hospital rather than the distribution 
of oral cancer. The values were not significant in this case. 
 
 
            The educational status of the patients was also looked at. This was done to look 
for differences in the incidence of oral cancers based on the level of their education. Since 
education would be an indirect indicator towards the socioeconomic status, the level of education 
can be used to assess the socioeconomic status as well. But the level of education was the same 
in both the cases group and the control group. The values were not statistically significant ( p = 
0.389).This value may be a representation of the profile of patients that come to the General 
Surgery OPD of the Christian Medical College and Hospital. They may not represent those with 
oral cancers alone. It was seen that most patients had primary education.  There was no 
significant difference in the education status of the cases and the controls.   
The fact that this was comparable among the cases and controls may be indicative of the 
level of education in the country. 
       The next parameter that was looked at was the prevalence of smoking among those 
with oral cancers and those without oral cancers. This shows a slightly increased number of oral 
cancers among those who smoked. Though the percentage of smokers was slightly higher, this 
difference was not found to be statistically significant. (p = 0.292). 
 There was a definite increase in the incidence of oral cancers in those who 
smoked more than 10 cigarettes a day
38
. Though the values were not statistically significant    (p 
= 0.072), seven out of the twelve who smoked more than 10 cigarettes per day had oral 
cancer.(58.3%). Those who smoked both beedis and cigarettes had a slightly higher incidence of 
oral cancers which may be a cumulative effect of both beedis and cigarettes. One patient who 
smoked cigars was found to have oral cancer. 
          As could be expected, there was an increased incidence of oral cancer among those 
who smoked for longer periods of time. But, once again, the values were not statistically 
significant.(p = 0.733) 
 
 The habit of consuming alcohol was found to be statistically significant in our 
study group (p = 0). This proves the fact that alcohol plays a causative role in oral cancers
39
. But 
there was no significant statistical difference that could be found among the cases and controls 
based on the frequency of consumption of alcohol (p = 0.363). There was no significant 
difference depending on the type of alcohol that was consumed either. Though it was not 
statistically significant it was seen that among those who consumed alcohol for less than 5 years 
only about 50% developed oral cancers. This percentage increased to 57% among those who 
consumed for 5 to 10 years. It was 100%  among those who had been consuming alcohol for 
more than 10 years.  
                    The significant difference was seen among the consumers of alcohol. There was an 
increased incidence among those who consumed alcohol for more than 20 years. But this value 
was not significant in the shorter duration. The same was true for chewing and smoking of 
tobacco where the values were more significant when the duration of the habit was more than 20 
years.  
 
   The   known causative factor that was studied was the chewing of tobacco
40
. 
There was some statistical significance for the chewing of tobacco and the causation of oral 
cancers. (p = 0.006). Those who chewed more often in one day (more than ten times a day)  
were found to be more affected ( 87.5%). There was no significant difference in the type of 
tobacco that was chewed but those taking both Khaini and Ghutkawere found to be more 
commonly affected as compared to those who chewed either one or plain betel nut. 
  Another factor that was seen to make a difference was the number of years of 
chewing tobacco. About 81% of those with oral cancers were found to have been chewing 
tobacco for more than twenty years. Even though this was not statistically significant, (p = 0.325) 
the effect of tobacco, smoked and smokeless is well documented. 
 
                       The number of patients who had risk factors of chewing or smoking tobacco were 
more in those who had oral cancers but these numbers were no significant. This may be because 
of the small sample size. This is comparable to the Indian statistics which show that Tobacco use 
and alcohol are known risk factors for cancers of the oral cavity. In India 57% of all men and 
11% of women between 15-49 years of age use some form of tobacco.
42 
 
  Oral hygiene of patients was also looked into. There were two patients who 
claimed they did not brush their teeth every day. Both were in the group of patients with oral 
cancers. The majority of patients brushed their teeth once a day. There was an equal distribution 
of cases and controls among this group. There was no significant difference among those who 
brushed their teeth twice daily.  Four (10%) had oral cancer among those who brushed twice 
daily while seven (17.5%) did not. This was not statistically significant(p= 0.063) 
Most patients did not have a dental visit before the diagnosis was made. There were very 
few patients who had more than one dental visit before diagnosis. More than 50% of patients did 
not have dental visits prior to their diagnosis. This may be the reason for many tumours 
presenting at a more advanced stage. They may have had premalignant lesions which could have 
been picked up earlier, or treated early. Regular dental check up for all patients should be 
proposed. There was no significance among cases and controls in regard to their dental visits, 
statistically (p=0.756) 
 
  Most cases and controls said they had no dental problems. The commonest 
problem that was seen was caries teeth. Presence of dental problems was almost equal among 
cases and controls. Lack of dental problems or, rather lack of awareness of dental problems 
could also be a contributory factor to the delayed recognition of oral malignancies. If the patients 
had had regular dental visits or had consulted a dentist for their dental problems there could be 
early identification of lesions. Sharp teeth and oral cavities were seen among a few but the 
numbers were not significant. Only one patient among those with oral cancer had dentures.  
Since the number is small, significance could not be derived. 
 
  We also looked into other chronic illnesses the patient might have like, Diabetes 
Mellitus and Hypertension. Though the values were not found to be statistically significant (p = 
0.292) longer duration of diabetes was found to correlate with presence of oral cancers. 
However, patients with 10 to 20 years of diabetes had oral cancer in 33.33% of cases while only 
in 12.5% of the controls.  But, this value also proved to be statistically not significant.(p=0.267) 
                        The number of patients with hypertension in the cases and the control group was 
almost the same. There was no significant difference in both groups. Here again it was seen that 
those with longer duration of hypertension seemed to have increased incidence of oral cancers. 
Whether this was due to the co-existence of diabetes or due to the increased age of  patients in 
this group was not clear. 
     Presence of Diabetes and hypertension was seen and analysed to look for a relationship 
between such chronic illnesses. Chronic diabetics were found to be more among the cases than 
the controls. 
 
                         This may be due to the fact that diabetes seems to promote the RAS/RAF/MAPK 
signal transduction pathway mainly by the induction of erbB2 and erb B3 receptors leading to 
increased cell proliferation leading to carcinogenesis
43
. Diabetes also enhances the expression  of 
H-ras and suppresses the expression of EGFR leading to increased cell proliferation. The 
pathways are presumed to lead to carcinogenesis
44
. But these values were not found to be 
statistically significant in our study. 
 
               The most common site of oral cancers seen in our centre was in the buccal 
mucosa followed by the lateral borders of the tongue.  
The percentages were as follows : 
Left lateral border of tongue : 22.5% 
Right lateral border of tongue : 15% 
Left buccalmucosa : 22.5% 
Right buccalmucosa : 25% 
Left lower alveolus : 10% 
Right lower alveolus: 2.5% 
Floor of the mouth 2.5% 
  The patients had presented to us mostly in Stage III with atleast a single node  
palpable. Most tumours were moderately differentiated. The majority of the lesions were 
between 2 to 4 cms.  
                       It was seen that most tumours that present to us in the OPD belong to size between 
2 to 4cm. This was followed by lesions that were more than 4 cm .The lesions that present in 
early stages where the tumour size was less than 2cm were relatively rare.  Lesions less than 2 
cm constituted 5% and those between 2 to 4 cm were 52.5%. Lesions more than 4 cm were 
42.5%. This may be classical of the patients presenting to General Surgery OPD in our centre. 
                        Nodes were found at presentation in the majority of the patients. 60% of the 
patients had atleast one node palpable at presentation. This again indicates the advanced   stage 
at which our patients present to us . 
                       From the graph it is seen that though most patients present with nodes, it was 
generally less than 3 cm. Only 3 patients of 24(12.5%) with nodal metastases had more than 3cm 
nodes which were bilateral. Most patients presented with nodes less than 3 cm and single which 
was 66.66%. Nodes that were more than 3cm less, than 6 cm and single were 12.5%; more than 3 
cm, less than 6 cm multiple were 8.33% and more than 3 cm less than 6 cm and bilateral were 
12.5% 
 
  This hospital-based case-control study evaluated the association between a marker 
for HPV infection and oral cavity squamous cell cancer (SCC) at a tertiary hospital setting in 
southern India.  Using the highly sensitive PCR, HPV DNA was examined in exfoliated cells of 
the buccal mucosa.  We enrolled 40 case patients and 40 controls and used similar procedures for 
data and specimen collection, and for HPV testing.  We found a nil prevalence of HPV DNA 
both among the cases and controls.   The PCR testing was done in the oral mucosal scrapings of 
both the cases and controls. Further typing of HPV was to be done in samples that were positive 
for HPV. The cases and the control samples in this study selection did not have any positive 
samples for the presence of HPV. 
  Differences in the distribution of other known risk factors for oral cavity SCC, 
specifically tobacco smoking, alcoholic beverage consumption and betel chewing, between cases 
and controls were unremarkable. 
            The samples taken from both the cases and the controls were not positive for 
Human Papillomavirus.  Patients in both the cases group and the control group were found to be 
negative for the virus in PCR studies. This was in contradiction to the results obtained from 
elsewhere in the world. The positivity for HPV in the normal mucosa is expected to be around 
5% with incidence increasing in pre malignant lesion. The incidence of HPV in the oral mucosa 
of patients with oral squamous cell cancers was expected to be around 40% based on studies 
done elsewhere in the world. The lack of positive result may indicate a different incidence of 
Human Papillomavirus in India. 
 
           The sample collection was done only by the principle investigator to make sure 
adequate sample was being collected by a uniform procedure in all the patients, both cases and 
controls. The samples were transported as soon as possible in ice packs to the virology 
department where they were refrigerated at 4
0
c to make sure the sample was viable.  Hence, there 
have been no issues with the method of sample collection or with the storage of the specimen. 
 
The confirmation of the adequacy of the sample was done by the betaglobin levels in 
each of the samples
68
. The betaglobin level in each of the samples was adequate. Therefore, the 
sample collection was adequate. 
 
  The samples were analysed by PCR. The methodology has been explained in 
detail. This was the standard method and there were no problems in the execution of the tests. 
The PCRs were confirmed using housekeeping genes. There were both positive and negative 
controls. RT – PCR testing was done which is considered to be the most sensitive test for DNA 
viruses. The results of similar PCR testing done for Human Papillomavirus done in cervical 
mucosa has shown excellent detection rates in carcinoma cervix in our laboratory. Since the 
laboratory in our Institution has WHO authorization, there is no doubt about the validity of our 
testing process. 
 
 
  
The kit that was used had a Collection Device which was HybriBio 
cell sampler ( HybriBio Limited, Hong Kong). 
 
The extraction kit used was HybriBio Extraction ( HybriBio Limited,  
Hong Kong). 
 
PCR amplification : a) Primers used : PGMY 09/11 ( Target size – 450bp)45 
   b) Housekeeping genes :Betaglobin (Target size – 230bp)46 
 
  The sample that was chosen to be studied was oral mucosal scrapings. Oral 
mucosal scrapings have been proven to be representative of the flora in the oral cavity
68
.  Hence, 
there has been adequate specimen collection and the method of collection and analysis has also 
been satisfactory. 
 
  This leaves us with the question of what the real reason for the lack of positive 
samples could be.  This may indicate a different pattern or trend among our patient population. 
Most of the patients were from low to middle socio economic strata and belonged to various 
states from across the country. The differences in the climatic and geographic distribution of the 
patients may also play a part in the absence of HPV in this sample population. 
                                                          
 
 
  There may different ethical, cultural and food habits in different areas. These may 
also be important in the causation of oral cancers. Some of these habits may also e protective in 
varying degrees. 
             We provide a brief review of statistics related to HPV and oral cavity SCC 
followed by a discussion of our study results. 
           During the last 15 years, HPV, the necessary cause of cancer cervix, has been 
causally linked with HNSCCs.  The association is strongest for oropharyngeal cancer than oral 
cavity or laryngeal SCCs (IARC, 2007)
47
.  Kreimer et al. (2005) in their review of HPV in 
HNSCCs worldwide (60 studies from 26 countries) found a significantly lower prevalence of 
HPV in oral cavity (23.50% of 2.642 cases; 95% CI=21.9-25.1) or laryngeal SCCs (24.0% of 
1,435; 95% CI=21.8-26.3) as compared to oropharyngeal SCC (35.6% of 969; 95% CI=32.6-
38.7)
48
.   
Molecular evidence provides support for certain types of HPV in the pathogenesis of a 
oral cavity SCC.  The IARC (2007) in their evaluation of HPV and oral SCC concluded that 
there is “sufficient evidence in humans for the carcinogenicity of HPV 16 in the oral cavity,” a 
conclusion based on strong evidence in exposed humans and sufficient evidence of 
carcinogenicity in experimental animals.  They also concluded that there was “limited evidence 
in humans for the carcinogenicity of HPV 18 in the oral cavity,” a conclusion based on limited 
evidence in humans and sufficient evidence of carcinogenicity in experimental animals (IARC, 
2007)
47
.  Kriemer et al. (2005) report that HPV16 accounted for a larger majority of HPV-
positive oropharyngeal SCCs (86.7%; 95% CI= 82.6-90.1) compared with HPV-positive oral 
SCCs (68.2%; 95% CI=64.4-71.9) and laryngeal SCCs (69.2%; 95% CI=64.0-74.0).  
Conversely, HPV18 was rare in HPV-positive oropharyngeal SCCs (2.8%; 95% CI=1.3-5.3) 
compared with oral cavity (34.1%, 95% CI=30.4-38.0) or laryngeal SCCs (17.0%, 95% CI=13.0-
21.6).  Aside from HPV16 and HPV18, other oncogenic HPVs were rarely detected in HNSCC.  
It was noted that tumor site-specific HPV prevalence was higher among studies from North 
America compared with Europe or Asia
48
.  
           While the results of our study may reflect the true association of HPV and oral 
cavity SCC in our setting, it is plausible that the findings may in fact be due to an alternate 
explanation (Hennekens, 1987)
49
.  Such alternate explanations may be due to the effects of bias, 
confounding or random error, which may produce spurious results leading to an absence of an 
association when it truly exists.  
Bias 
           Perhaps the most serious problem hampering the validity of epidemiologic studies 
is the effect of measurement error in study variables.  We do not perceive this to be a major 
source of bias in this study.  In our study, the chance of bias was decreased by using an accurate 
method of identification of Human Papillomavirus. With regard to the detection of HPV, our use 
of PCR techniques and liquid-phase, immunocaptured hybridization has eliminated the severe 
misclassification of HPV status by the first generation of molecular epidemiology studies
50,51
 
(Franco, 1991; Schiffman and Schatzkin, 1994).Kreimer et al. (2005)
48 
noted that HPV-16 and 
HPV-18 accounted for 16% and 8%, respectively of cases with HPV-positive oral cavity SCC; a 
slightly higher proportion of HPV prevalence may be detected by the inclusion of testing for 
other high-risk types of HPV found in the oral cavity such as types 31, 33, 35, 56, 58 and 68 
which accounted for another 1.5%.   
         We did not perform serological tests to corroborate the negative HPV results in this 
study.  A high prevalence of serum antibodies to HPV-16 oncoprotein E6 and E7, using enzyme-
linked immunosorbent assay (ELISA), has been found to be a useful marker of past HPV-16 
exposure (Viscidi et al., 2003)
54.  D‟Souza et al. (2007) in a US-based case-control study of HPV 
and oropharyngeal cancer (cases, n=100; controls, n=200) found a prevalence of 72% of HPV-16 
DNA in tumor specimens; serum antibodies against HPV-16 oncoprotein E6 or E7, or both were 
found in 64% of case patients and in 4% of control patients.  With regard to negative HPV 
results, 28% of case patients had a negative HPV-16 DNA in tumour specimens, while 36% of 
case patients had a negative HPV-16 E6 or E7 serologic status. Among controls, 96% were sero-
negative for HPV-16 oncoproteins
55
.     
         Another reason for the high negative PCR results may be that the population studied 
may have lesser degree of high risk sexual behavior as compared to that of the various other 
populations studied in other studies. High-risk sexual behaviors have been found to be associated 
with HPV.  Gillison et al. (2000) detected HPV more commonly among patients with more than 
one sexual partner and from those who practiced oral sex
56
.  WHO data on sexual health 
behaviour indicators in India is scarce (WHO, 2010)
57
.  However, the few available studies 
suggest that oral sex is not a popular practice due to the cultural bias against such behaviors 
(Avasthi et al., 2008)
58
.  Other risk factors for increased risk of HPV infection such as premarital 
sex and having multiple partners are also less prevalent in India (15% -20%)
59,60
 (Burchell et al., 
2006; Joshi and Chauhan, 2011) as compared to the prevalence noted in western countries 
(75%)
61
 (Finer, 2007).  Because of the sensitive nature of questions and the potential ensuing 
psychological risk compounding the psychological trauma due to cancer diagnosis, we did not 
elicit detailed history on sexual behavior among the study group.  But it has been clear from the 
above mentioned studies that the population under study may differ from their counterparts in 
other studies in their sexual behavior. 
         Since ours was a case-control study, the chances of outcome miscalculation was 
very less. With regard to the outcome, case-control studies are unlikely to be affected by 
outcome misclassification as in cohort studies which are prone to this error as pre-invasive 
conditions may be classified as disease end points. Kriemer et al. (2005) suggest that 
misclassification of advanced oropharyngeal SCCs as oral cavity SCCs may have inflated the 
prevalence of HPV infection in oral cancers in Asia
48
.  All cases in this study were biopsy 
confirmed, and did not include pre-invasive conditions such as leukoplakia.  Most cases (45%) 
were in Stage III  of the oral cavity SCC at the time of diagnosis, minimizing the bias due to 
misclassification.    
         Other studies have focused on the areas of the oral cavity that have higher 
predilection for HPV
55
.  In the present study, the case group comprised of oral cavity cancer 
which included tumours of the lips, floor of the mouth, gum, palate, the anterior two-thirds of the 
tongue and the floor of the mouth below the tongue.  Previous studies have shown that the most 
common sites for HPV-related head and neck cancers are cancers are the tonsil or base of the 
tongue (Syrjänen, 2005; Auluck et al., 2010) which are parts of the oropharynx.  HPV infection 
was less strongly associated with other oral sites, such as the ventrolateral tongue, gingivae, 
cheek, palate, or floor of the mouth, where tobacco and alcohol are major etiological factors 
(Auluck et al., 2010)
62,63
.  A case-control study of HPV and oropharynegal cancer byD‟Souza et  
al. (2007) minimized selection bias by restricting case enrollment to primarily those with tumors 
located on the tonsil or base of tongue found a HPV prevalence of 40%
55
.     Our studywas 
specifically designed to evaluate the association between HPV infection and oral cavity SCC. 
Oral SCCs are more heterogenous with regard to the tumour location, anatomical sites, and are 
less likely to harbor the HPV than oropharyngeal SCC.  Hence, in our study we have widened 
the area of the search for the Human Papillomavirus. The fact that we did not find positive 
results shows  
 
Confounding 
            Tobacco smoking (IARC, 2004) or chewing (IARC, 2007) and alcoholic beverage 
drinking are strongly associated with oral cavity cancer, with attributable fractions of about 90% 
(IARC, 2007). 
64,47
.We did not find significant differences in the distribution of these established 
risk factors among cases and controls in our study.  However, some tumours occur in subjects 
who are not exposed to known risk factors, and only a fraction of exposed subjects develop 
tumours.  This suggests that other exposures may be independently involved or act as co-factor 
Random error 
                Although we noted  nil prevalence in this study, it is not an implausible finding.  
The International Agency for Research on Cancer (IARC) noted wide variations in HPV  
prevalence in oral cavity SCCs with studies reporting estimates ranging from 0% to 100% 
(IARC, 2007)
47
.  However, in their assessment of pooled data from different countries, they  
included only studies that had more than 40 cases and had tested for the presence of HPV using 
PCR methods. The prevalence in these studies ranged from 4% to 80%.  Kreimer et al. (2005) 
state that small sample size and publication bias complicate the assessment of the prevalence of 
HPV in HNSCCs beyond the oropharynx; they note that HPV prevalence was inversely 
proportional study sample size notably in oral cavity and larynx SCCs
48
.  Moststudies clustered 
between 10 and 100 cases; only five studies of oral cavity SCC included more than 100 cases 
(Herrero et al., 2003; Schwartz et al., 1998; Smith et al., 2004; Nagpaletal., 2002; Chang et al., 
2003)
52,53,65,66
.  The larger studies tended to show an overall prevalence that was substantially 
lower than the average.  For example, in the large IARC multicentric study, the prevalence of 
HPV in oral cavity SCC was 3.9% based on 766 cases from 9 countries
52
  (Herrero et al., 2003), 
whereas a study in India reported a prevalence of 73.6% based on 91 cases 
67
(Balaram et al., 
1995).  These findings suggest a selection bias wherein cases were preferentially included in the 
studies or that only studies reporting a high prevalence were published.  Thus, conservative 
estimates of HPV prevalence estimates would be more realistic in power computations for 
studies of HPV and oral cavity SCC. 
We estimated the study size based on 40% HPV prevalence among cases and 10% in 
controls and α error of 5.  In light of the very wide variation in prevalence estimates and that 
HPV estimates in literature are mainly influenced by small studies, future estimates of HPV 
prevalence for power computation should be rather high.  Using a conservative estimate of HPV 
prevalence estimates such as 5% prevalence in cases and 1% among controls, a sample size of 
285 cases and 285 controls would be required to detect an effect. In future studies, using a higher 
sample size may bring out hitherto unknown factors to light. The results of our study may, in fact 
be the actual prevalence of HPV in the oral cavity of the Indian population. There may be other 
factors which may be the reason behind the absence of Human Papillomavirus in the oral cavity 
of Indians. Factors like the dietary practices of the population and other cultural differences may 
also contribute to the absence of HPV in these people. 
 
  
 
                 CONCLUSIONS 
 
 
 
 
 
 
 
 
 
1. There may be different factors responsible for oral cancers in the patients who present to 
the out-patient department in the Christian Medical college, Hospital, Vellore as can be 
seen from our study. There may be other reasons for the absence of Human 
Papillomavirus in this sub-group of patients. The results may be representative of the 
population that comes to this out patient department for treatment. 
 
2. It was seen that there was a male preponderance in the patients with oral cancers which is 
comparable to studies done elsewhere. The rising use of tobacco products among both 
sexes may decrease this difference in the coming years. 
 
 
3. Though not statistically significant the demographic pattern of patients with oral 
squamous cell cancers matched those done elsewhere.  
 
4. More studies can be done in the future which may indicate the other reasons as why 
Human papilomavirus was not found in the patients presenting to our OPD which will 
lead to a different approach to the diagnosis and the management of oral squamous cell 
cancers. 
 
 
  
                     LIMITATIONS 
 
 
 
 
 
 
 
 
 
 
 
 
1. The number of cases and controls were calculated based on the existing literature. The 
numbers came to approximately 36 in each arm as the incidence in the general population 
was about 40%. Hence the sample size was small, thereby causing difficulties in the 
analyses of facts. 
 
2. Another feature that restricted the number of cases that were included in the study was 
the cost of the kit and the PCR testing. Hence, the numbers were kept to the minimum 
possible. 
 
3. The RT PCR results were negative, hence further correlation between various risk factors 
could not be studied in detail. 
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APPENDIX 
 
 
 
 
 
 
 
 
A:  INFORMED CONSENT 
A study is being conducted in Christian Medical College and Hospital in the General 
Surgery OPD to study the presence of Human Papillomavirus (HPV) in the oral cavity and to see 
whether it is related to the causation of cancer of the oral cavity. 
   The common causative factors of oral cancer are tobacco chewing and 
alcohol consumption. It has been seen in earlier studies that HPV also plays an important role in 
the causation of cancer. This study aims at evaluating the presence of HPV in the mouth and its 
association with oral cancers. 
   In this study, scrapings from your mouth will be taken using a small brush 
and the sample sent to the Virology Department. The presence of HPV will be evaluated using a 
kit and its type identified. You will also be required to fill a questionnaire in regard to your 
habits. Confidentiality will be maintained. 
   It has been seen that HPV can be found in the mouth of persons without 
any oral lesions. In that case, if you prefer it, the results of the study will be informed to you. 
You will have to have regular check up and evaluate immediately if you develop oral lesions. 
   The decision to participate in this study is purely voluntary. Your 
treatment will continue regardless of your participation in the study. Your decision will not affect 
your treatment in this hospital in any way. 
If you have any doubts or questions, kindly contact, Department of 
General Surgery. 
Christian Medical college and Hospital.Ph. No: 9944807738 
B :DATA ENTRY FORM  
EVALUATION OF RELATIVE RISK OF ORAL SQUAMOUS CELL CARCINOMA IN 
PATIENTS WITH HUMAN PAPILLOMA VIRUS  
1. S. no. 
 
2. Name :                                             3. Hospital number: 
 
4. Age:                                                5. Sex: 
 
6. Address: 
 
7. Phone number: 
 
8. Education: 
9. Occupation: 
10. State : 
C: QUESTIONNAIRE FOR RISK FACTOR 
ANALYSIS IN ORAL CANCERS 
 
1. Age     
 
2. Sex    1.Male                      2. Female 
 
3.State    1. Tamil Nadu         2.Andhra Pradesh        3.West Bengal    4.  North Eastern states        
5. Others 
 
4. Smoking History  
a. Smoker    1. Yes                  2.No 
b. Smokes    1. Beedis             2. Cigarettes        3.Cigar         
4.pipe                  5. Reverse smoking 
c. No. of years: 
 
 
 
5. Alcohol consumption:  
a.Consumer: 1Yes                      2.No          
b. Consumes: 1. wine                 2. arrack            3.beer 
c. Frequency : 
 
d. Number of years:  
 
 
6. Chews paan : a.1.Yes                 2.No 
b. Type of paan : 
c.  Frequency :  
d. Number of years: 
 
7. Dental hygiene : 
 a. Brushes teeth 1. Yes, twice daily 2. Yes, once daily    3. No 
 
b. dental visits: 1.Yes, regularly           2.No. 
 
c. History of caries teeth/ cavities. 
 
d. Dentures: 1. Yes    2. No 
 
8. Other co-morbid illnesses: 
a. Diabetes : 1.Yes          2. No 
b. Duration : 
c. Hypertension: 1. Yes          2. No 
d. Duration : 
 
 
9. Site of the tumour. 
a. buccal mucosa      b. lateral border of the tongue 
c. alveolus                 d. floor of the mouth. 
 
 
10. Size of the tumour. 
 
 
11. Degree of differentiation: 
 
 
 
 
12. Presence of neck nodes: 
 
 
13. TNM Staging 
 
 
